Cyngn Inc. announced an organizational realignment to focus on enterprise customers and accelerate growth using AI-driven efficiency. The company streamlined management, consolidated teams, and enhanced AI tools to improve product development and sales execution. They also strengthened governance and compliance, aiming to complete SOC 2 and ISO 27001 certifications by year-end. These changes position Cyngn to scale its autonomous industrial vehicle technology, particularly its DriveMod Tugger product, for logistics and manufacturing sectors.
Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...
CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...
At the 13th annual Muhammad Ali Humanitarian Awards in Louisville, Colin Kaepernick was honored as Humanitarian of the Year for his activism and entrepreneurship, including founding literacy platform Lumi and Know Your Rights Camp. The event also rec...
Cabaletta Bio announced Phase 1/2 clinical data for rese-cel, a CAR T cell therapy targeting autoimmune diseases, showing durable benefits without immunomodulators across dermatomyositis, lupus nephritis, and systemic sclerosis patients. All dermatom...
Despite strong AI demand and record growth from cloud providers like AWS, AI data center stocks, especially former Bitcoin miners turned AI hosts, have fallen sharply due to tightening capital markets and political restrictions. Companies like Cipher...
